© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
May 25, 2021
The TAVT-45 formulation of abiraterone acetate consists of granules for oral suspension.
May 20, 2021
Ranjith Ramasamy, MD, explains how the oral testosterone capsule Jatenzo works and touches on key findings from a recent study of the treatment.
May 17, 2021
In contrast, following development of metastatic castration-resistant prostate cancer, time to castration resistance did not influence overall survival.
May 04, 2021
The approval was based on data from the phase 3 ARCHES trial.
April 21, 2021
Hamilton discusses findings from a recent study published in European Urology.
April 20, 2021
The novel combination of apalutamide plus abiraterone and prednisone had previously met the primary end point of radiographic progression-free survival in the phase 3 ACIS trial.
April 08, 2021
The genetic alterations in circulating tumor cells were linked to response or resistance to abiraterone acetate and enzalutamide.
April 05, 2021
Dr. Ronald S. Swerdloff says Jatenzo showed “no evidence of liver toxicity.”
March 26, 2021
Jatenzo is approved by the FDA as a testosterone replacement therapy for men with certain forms of hypogonadism.
March 11, 2021
The application for the investigational testosterone replacement therapy is supported by findings from the pivotal phase 3 ReTUNE trial, as well as a 6-month extension study of that trial.